Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-23-000171 General Corporate
Debt relative to revenue 31th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
228.31% · OPTIONAL · VALID
Capex intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.77% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
52.51% · OPTIONAL · VALID
Revenue growth 11th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
39.70% · CORE · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.57% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-9.27% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.86% · OPTIONAL · VALID
SBC intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
26.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 70.14%
Current 228.31%
Delta 158.17% Capex Intensity Decreased
Previous 6.01%
Current 5.77%
Delta -0.24% Cash Generation Increased
Previous 28.59%
Current 52.51%
Delta 23.91% Growth Decreased
Previous 48.22%
Current 39.70%
Delta -8.51% Margin Increased
Previous 77.56%
Current 77.57%
Delta 0.01% Profitability Increased
Previous -14.51%
Current -9.27%
Delta 5.24% R And D Intensity Increased
Previous 21.63%
Current 22.86%
Delta 1.23% Sbc Intensity Decreased
Previous 27.51%
Current 26.00%
Delta -1.51% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.